Cargando…

An Improved NAT Assay with Enhanced Sensitivity for HBV for Donor Blood Screening

Detalles Bibliográficos
Autor principal:	Chatterjee, Kabita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574497/ https://www.ncbi.nlm.nih.gov/pubmed/23436970 http://dx.doi.org/10.4103/0974-2727.105595

Ejemplares similares

Comparison of Procleix Ultrio Elite and Procleix Ultrio NAT Assays for Screening of Transfusion Transmitted Infections among Blood Donors in India
por: Chaurasia, Rahul, et al.
Publicado: (2016)

Evaluation of the Procleix Ultrio Plus ID NAT assay for detection of HIV 1, HBV and HCV in blood donors
por: Makroo, Raj Nath, et al.
Publicado: (2015)

Effectiveness of blood donor screening by HIV, HCV, HBV‐NAT assays, as well as HBsAg and anti‐HBc immunoassays in Germany (2008–2015)
por: Fiedler, Sarah A., et al.
Publicado: (2019)

Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience
por: Chaurasia, Rahul, et al.
Publicado: (2014)

HBV Genotyping in HBsAg-Positive Blood Donors from Southwestern Iran
por: Kohshour, Mojtaba Oraki, et al.
Publicado: (2010)

Chemiluminescence brings renaissance in TTI screening: Primi experientia
por: Rout, Diptiranjan, et al.
Publicado: (2017)

Nearly half of Ultrio plus NAT non-discriminated reactive blood donors were identified as occult HBV infection in South China
por: Ye, Xianlin, et al.
Publicado: (2019)

Screening Blood Donors at Risk for Malaria: Reply to Hänscheid et al.
por: Benito, A., et al.
Publicado: (2002)

Polymerase Chain Reaction for Screening Blood Donors at Risk for Malaria: Safe and Useful?
por: Hänscheid, T., et al.
Publicado: (2002)

Vaccination to blood donors()
por: Rodríguez García, Juan, et al.
Publicado: (2022)

Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing
por: Bottecchia, Marcelle, et al.
Publicado: (2015)

Donated Blood Screening for HIV, HCV and HBV by ID-NAT and the Residual Risk of Iatrogenic Transmission in a Tertiary Care Hospital Blood Bank in Puebla, Mexico
por: Sosa-Jurado, Francisca, et al.
Publicado: (2023)

Blood group phenotype frequencies in blood donors from a tertiary care hospital in north India
por: Agarwal, Nitin, et al.
Publicado: (2013)

Donor hemovigilance: Delayed vasovagal reaction with injury in a blood donor
por: Sachdev, Suchet, et al.
Publicado: (2015)

Frequency of ABO and rhesus blood groups in blood donors
por: Chandra, Tulika, et al.
Publicado: (2012)

Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil
por: Corrêa, Angelita Silva de Miranda, et al.
Publicado: (2018)

KIs Virus and Blood Donors, France
por: Biagini, Philippe, et al.
Publicado: (2012)

Parvovirus 4 in Blood Donors, France
por: Touinssi, Mhammed, et al.
Publicado: (2010)

Blood donor deferrals: Can this be reduced?
por: Jashnani, Kusum D., et al.
Publicado: (2011)

The Prevalence of Yersinia Yop-Specific Iga Antibodies in Iranian Healthy Blood Donors and Evaluation of Blood Culture of Seropositive Donors
por: TIMORI NAGHADEH, Hossein, et al.
Publicado: (2016)

Use of a NAT-based assay to improve the surveillance system and prevent transfusion-transmitted malaria in blood banks
por: Rocha, Daniele, et al.
Publicado: (2020)

Parvoviruses in Blood Donors and Transplant Patients, Italy
por: Vallerini, Daniela, et al.
Publicado: (2008)

Hepatitis C Virus in Blood Donors, Brazil
por: Torres, Kátia Luz, et al.
Publicado: (2009)

Human Gyrovirus in Healthy Blood Donors, France
por: Biagini, Philippe, et al.
Publicado: (2013)

Sensitivity of assays for TSH-receptor antibodies
por: Bitcon, V., et al.
Publicado: (2016)

Prevalence of Occult Hepatitis B Virus Infection in Blood Donors with Negative ID-NAT in Switzerland
por: Zbinden, Andrea, et al.
Publicado: (2022)

Evaluation of three commercial kits for mycoplasma NAT assays: selection and quality improvement
por: Dorange, Fabien, et al.
Publicado: (2011)

Commentary on: A study of genotype, mutants and nucleotide sequence of HBV in Pakistan: Genotype, mutants, and nucleotide sequence of HBV
por: Jazayeri, Seyed Mohammad
Publicado: (2011)

SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
por: Anft, Moritz, et al.
Publicado: (2023)

Enhancing targeted transgene knock‐in by donor recruitment
por: Jiao, Guanyi, et al.
Publicado: (2021)

Human Herpesvirus 8 in Healthy Blood Donors, Argentina
por: Pérez, Celeste L., et al.
Publicado: (2010)

Seroprevalence of Toscana Virus in Blood Donors, France, 2007
por: Brisbarre, Nadège, et al.
Publicado: (2011)

Weak D prevalence among Indian blood donors
por: Makroo, R. N., et al.
Publicado: (2010)

Leishmania infantum Infection in Blood Donors, Northeastern Brazil
por: Monteiro, Daniela C.S., et al.
Publicado: (2016)

Motivating Factors among Blood Donors in Pune, India
por: Ahmad Farooqui, Iqbal, et al.
Publicado: (2018)

Can adequate hemodynamic management of brain-dead donors improve donor organ procurement?
por: Thet, Myat Soe, et al.
Publicado: (2022)

Profile of deferral of blood donors in regional blood transfusion center in North India
por: Sharma, Tanya, et al.
Publicado: (2013)

Incidence of Kell blood group in blood donors: A population-based study
por: Rani, Rekha, et al.
Publicado: (2015)

Issues Related to High-Sensitivity Troponin Assays
por: Tada, Masafumi, et al.
Publicado: (2022)

Prevalence of HBV and HCV among blood donors in Kosovo
por: Fejza, Hajrullah, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_aasvlmsefd63lhomc6mnlo4mad